AAAAAA

   
Results: 1-12 |
Results: 12
Functional evaluation of p53 and PTEN gene mutations in gliomas
Authors: Kato, H Kato, S Kumabe, T Sonoda, Y Yoshimoto, T Kato, S Han, SY Suzuki, T Shibata, H Kanamaru, R Ishioka, C
Citation: H. Kato et al., Functional evaluation of p53 and PTEN gene mutations in gliomas, CLIN CANC R, 6(10), 2000, pp. 3937-3943
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor
Authors: Shafman, TD Levitz, S Nixon, AJ Gibans, LA Nichols, KE Bell, DW Ishioka, C Isselbacher, KJ Gelman, R Garber, J Harris, JR Haber, DA
Citation: Td. Shafman et al., Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor, GENE CHROM, 27(2), 2000, pp. 124-129
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
Authors: Han, SY Kato, H Kato, S Suzuki, T Shibata, H Ishii, S Shiiba, K Matsuno, S Kanamaru, R Ishioka, C
Citation: Sy. Han et al., Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay, CANCER RES, 60(12), 2000, pp. 3147-3151
Mutational analysis of p51A/TAp63 gamma, a p53 homolog, in non-small cell lung cancer and breast cancer
Authors: Sunahara, M Shishikura, T Takahashi, M Todo, S Yamamoto, N Kimura, H Kato, S Ishioka, C Ikawa, S Ikawa, Y Nakagawara, A
Citation: M. Sunahara et al., Mutational analysis of p51A/TAp63 gamma, a p53 homolog, in non-small cell lung cancer and breast cancer, ONCOGENE, 18(25), 1999, pp. 3761-3765
A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers
Authors: Yoshioka, T Gamoh, M Shineha, R Ishibashi, S Shibata, H Suzuki, T Murakawa, Y Kato, S Shimodaira, H Kato, S Ishioka, C Kanamaru, R
Citation: T. Yoshioka et al., A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers, INTERN MED, 38(11), 1999, pp. 844-848
Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease
Authors: Nichols, KE Levitz, S Shannon, KE Wahrer, DCR Bell, DW Chang, G Hegde, S Neuberg, D Shafman, T Tarbell, NJ Mauch, P Ishioka, C Haber, DA Diller, L
Citation: Ke. Nichols et al., Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease, J CL ONCOL, 17(4), 1999, pp. 1259-1266
FDG PET evaluation of residual masses and regrowth of abdominal lymph nodemetastases from colon cancer compared with CT during chemotherapy
Authors: Yoshioka, T Fukuda, H Fujiwara, T Iwata, R Ido, T Murakawa, Y Gamo, M Ishioka, C Kanamaru, R
Citation: T. Yoshioka et al., FDG PET evaluation of residual masses and regrowth of abdominal lymph nodemetastases from colon cancer compared with CT during chemotherapy, CLIN NUCL M, 24(4), 1999, pp. 261-263
Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma
Authors: Osada, M Ishioka, C Ichinohasama, R Kadowaki, I Murakawa, Y Watanabe, M Kanamaru, R Ikawa, S
Citation: M. Osada et al., Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma, ANTI-CAN DR, 14(2), 1999, pp. 107-114
BRCA1 mutation testing for Japanese patients with ovarian cancer in breastcancer screening
Authors: Yamashita, Y Sagawa, T Fujimoto, T Sugawara, T Yamada, H Hoshi, N Sakuragi, N Ishioka, C Fujimoto, S
Citation: Y. Yamashita et al., BRCA1 mutation testing for Japanese patients with ovarian cancer in breastcancer screening, BREAST CANC, 58(1), 1999, pp. 11-17
Effects of p51/p63 missense mutations on transcriptional activities of p53downstream gene promoters
Authors: Kato, S Shimada, A Osada, M Ikawa, S Obinata, M Nakagawara, A Kanamaru, R Ishioka, C
Citation: S. Kato et al., Effects of p51/p63 missense mutations on transcriptional activities of p53downstream gene promoters, CANCER RES, 59(23), 1999, pp. 5908-5911
Common nonsense mutations in RAD52
Authors: Bell, DW Wahrer, DCR Kang, DH MacMahon, MS FitzGerald, MG Ishioka, C Isselbacher, KJ Krainer, M Haber, DA
Citation: Dw. Bell et al., Common nonsense mutations in RAD52, CANCER RES, 59(16), 1999, pp. 3883-3888
The transcriptional activities of p53 and its homologue p51/p63: Similarities and differences
Authors: Shimada, A Kato, S Enjo, K Osada, M Ikawa, Y Kohno, K Obinata, M Kanamaru, R Ikawa, S Ishioka, C
Citation: A. Shimada et al., The transcriptional activities of p53 and its homologue p51/p63: Similarities and differences, CANCER RES, 59(12), 1999, pp. 2781-2786
Risultati: 1-12 |